Condition: Gastric Lesion · Gastric Precancerous Condition · Gastric Cancer · Sponsor: Institut Pasteur
The goal of this study is to characterize and validate a signature of circulating biomarkers in plasma, associated with the presence of gastric preneoplasia in patients with preexisting gastric lesion compared with a control group. For this purpose: * Patients with pre-existing gastric lesions will be invited to participate to this study. If they are willing to participate an additional blood sample (9 mL) will be collected at the time of the blood collection performed during their routine care * Healthy subjects will be invited to participate to constitute the control group. If they are willing to participate a blood sample (9 ml) will be drawn specifically for this study
This description comes directly from the study's public registry record.
Eliette TOUATI, PhD · +33140613785 · eliette.touati@pasteur.fr
Olivia CHENY, PhD · olivia.cheny@pasteur.fr
Always discuss trial participation with your own doctor first.
| Ambroise Paré Teaching Hospital (AP-HP) | Boulogne-Billancourt, France | Completed |
| Beaujon Teaching Hospital (AP-HP) | Clichy, France | Recruiting |
| Kremlin Bicêtre Teaching Hospital (AP-HP) | Le Kremlin-Bicêtre, France | Recruiting |
| Cochin Teaching Hospital (AP-HP) | Paris, France | Recruiting |
| INVOLvE - Investigation et volontaires en santé humaine (Institut Pasteur) | Paris, France | Recruiting |
| Saint Antoine Teaching Hospital (AP-HP) | Paris, France | Recruiting |
| Saint Antoine Teaching Hospital (AP-HP) | Paris, France | Not Yet Recruiting |
| Saint Louis Teaching Hospital (AP-HP) | Paris, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05854368